APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems

被引:0
|
作者
Baptista-Leite, Ricardo [1 ,2 ]
Lopes, Henrique [1 ]
Franco, Diogo [1 ]
Clemens, Timo [2 ]
Brand, Helmut [2 ]
机构
[1] Univ Nova Lisboa, NOVA Ctr Global Hlth, NOVA IMS, Lisbon, Portugal
[2] Maastricht Univ, CAPHRI, Dept Int Hlth, Fac Hlth Med & Life Sci, Maastricht, Netherlands
来源
JOURNAL OF PUBLIC HEALTH-HEIDELBERG | 2024年
基金
英国科研创新办公室;
关键词
Public health; People who inject drugs (PWID); Hepatitis C; Vulnerable groups; Care cascade; Service quality improvement; DISEASE; VIRUS; RISK; HIV; HCV;
D O I
10.1007/s10389-024-02276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim The "APPEAL" toolkit was developed to address the challenges in diagnosing people who inject drugs (PWID) with hepatitis C (HCV) and engaging them with healthcare systems. It introduces an ecosystemic approach based on health and well-being literacy across awareness, prevention and diagnosis dimensions of the hepatitis C's care cascade (CC) for PWID.Subject and methods The framework incorporated a scoping review and thematic analysis of 54 studies, alongside contributions from 57 hepatitis C key opinion leaders across seven countries. The toolkit is structured around five main axes: problems, solutions, outputs, outcomes and feedback process, employing a holistic perspective that considers economic, legal and social contexts. Eighteen policy prescriptions (PP) are proposed and supported by selective references to ensure relevance and applicability.Results The APPEAL toolkit facilitates a strategic workflow for policymakers, health authorities and patient advocacy organizations, guiding them through action flowcharts to evaluate and enhance their interventions within the hepatitis C's CC for PWID. Notably, its implementation demonstrated potential in identifying and attracting PWID to hepatitis C treatment pathways, contributing to increased diagnostics, education on risk behaviours and raising overall disease awareness. The toolkit's intelligent cycle system supports accountability, enabling continuous data-driven improvement and innovation in addressing hepatitis C.Conclusion The APPEAL toolkit was developed to attract PWID living with HCV to healthcare systems in a proactive manner. By managing information and fostering education on HCV, it aims to amplify awareness, prevention and diagnosis. The toolkit's design and functionality underscore the importance of continuous quality improvement and the potential for its use in internal or external quality audits of healthcare services related to hepatitis C.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection
    Artenie, Andreea Adelina
    Hickman, Matthew
    Vickerman, Peter
    Stone, Jack
    Grebely, Jason
    Bruneau, Julie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
  • [2] Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
    Roser, Patrik
    Brunstein, Mona
    Specka, Michael
    Timm, Joerg
    Kuehnhold, Stefan
    Schifano, Fabrizio
    Bonnet, Udo
    Scherbaum, Norbert
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [3] Modeling the spread of hepatitis C virus amongst people who inject drugs
    Greenhalgh, David
    Al-Rashidi, Nader
    ENGINEERING REPORTS, 2022, 4 (10)
  • [4] The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran
    Haji-Maghsoudi, Saiedeh
    Tavakoli, Fatemeh
    Mehmandoost, Soheil
    Nasiri, Naser
    Haghdoost, Ali Akbar
    Sharifi, Hamid
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [5] Hepatitis C Treatment in People Who Inject Drugs
    Benjamin Eckhardt
    Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 416 - 425
  • [6] Barriers to HIV and Hepatitis C care for people who inject drugs in Colombia
    Borda, Juan P.
    Friedman, Hannah L.
    Castano, Guillermo A.
    Rodriguez, Henry A.
    Munoz, Carlos F.
    Tofighi, Babak
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (05): : 633 - 638
  • [7] Therapy of chronic hepatitis C in people who inject drugs: focus on adherence
    Frankova, Sona
    Jandova, Zuzana
    Jinochova, Gabriela
    Kreidlova, Miluse
    Merta, Dusan
    Sperl, Jan
    HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [8] Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs
    Martinello, Marianne
    Dore, Gregory J.
    Matthews, Gail, V
    Grebely, Jason
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (02) : 371 - 393
  • [9] The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania
    Mohamed, Zameer
    Rwegasha, John
    Kim, Jin U.
    Shimakawa, Yusuke
    Poiteau, Lila
    Chevaliez, Stephane
    Bhagani, Sanjay
    Taylor-Robinson, Simon D.
    Thursz, Mark R.
    Mbwambo, Jessie
    Lemoine, Maud
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (12) : 1438 - 1445
  • [10] Widespread hepatitis C virus transmission network among people who inject drugs in Kenya
    Akiyama, Matthew J.
    Khudyakov, Yury
    Ramachandran, Sumathi
    Riback, Lindsey R.
    Ackerman, Maxwell
    Nyakowa, Mercy
    Arthur, Leonard
    Lizcano, John
    Walker, Josephine
    Cherutich, Peter
    Kurth, Ann
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 147